Induction chemotherapy plus chemoradiotherapy with or without aspirin in high risk rectal cancer (ICAR)
Souza, J.C.E.S.O.D., Araujo, R., Valadão, M., Carrara, C., Barbosa, M.Á, Guimarães, R., Carvalho, J., Kovaleski, G., Small, I., Marins, A., Victorino, A.P., Gil, R., Jesus, J.P., de Araujo, L.H., de Melo, A.C.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
1506TiP A single-arm, phase II study of amivantamab (AMI), lazertinib (L) and pemetrexed (P) for first-line treatment of recurrent/metastatic non-small cell lung cancers (NSCLCS) with epidermal growth factor receptor mutations in Exons 19 or 21 (EGFR 19/21): AMIGO 1 (LACOG0821)
Nassib William Junior, W., de Lima Araújo, L.H., Da Silva, F.A.F., Gelatti, A.C., Silva, E.H.C., Silva Melo Cruz, F.J., De Castro, G., Abdalla, K.C., Zereu, M., De Marchi, P.R., Bandeira Aleixo, S., Cunha Sousa Oliveira, S., Cardoso Motta, T., de Jesus, R., Rebelatto, T.F.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article